The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Gilman will be responsible for all business development and portfolio strategy efforts globally.
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
Acceptance based on results from the phase 3 KEYNOTE-091 trial
Subscribe To Our Newsletter & Stay Updated
